These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 34800627

  • 1. The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury.
    Bland AR, Payne FM, Ashton JC, Jamialahmadi T, Sahebkar A.
    Pharmacol Res; 2022 Jan; 175():105986. PubMed ID: 34800627
    [Abstract] [Full Text] [Related]

  • 2. Activation of G protein-coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardium against ischemia/reperfusion injury by reducing mitochondrial dysfunction and mitophagy.
    Feng Y, Madungwe NB, da Cruz Junho CV, Bopassa JC.
    Br J Pharmacol; 2017 Dec; 174(23):4329-4344. PubMed ID: 28906548
    [Abstract] [Full Text] [Related]

  • 3. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore.
    Vélez DE, Mestre-Cordero VE, Hermann R, Perego J, Harriet S, Fernandez-Pazos MLM, Mourglia J, Marina-Prendes MG.
    J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218
    [Abstract] [Full Text] [Related]

  • 4. The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury.
    Ong SB, Samangouei P, Kalkhoran SB, Hausenloy DJ.
    J Mol Cell Cardiol; 2015 Jan; 78():23-34. PubMed ID: 25446182
    [Abstract] [Full Text] [Related]

  • 5. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.
    Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z.
    Eur J Pharmacol; 2009 Feb 14; 604(1-3):111-6. PubMed ID: 19135050
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury.
    Miura T, Tanno M.
    Cardiovasc Drugs Ther; 2010 Jun 14; 24(3):255-63. PubMed ID: 20490903
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress.
    Townsend PA, Davidson SM, Clarke SJ, Khaliulin I, Carroll CJ, Scarabelli TM, Knight RA, Stephanou A, Latchman DS, Halestrap AP.
    Am J Physiol Heart Circ Physiol; 2007 Aug 14; 293(2):H928-38. PubMed ID: 17483234
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW, Yang F, Cheng SZ, Liu Y, Wan LH, Cong HL.
    Cardiovasc Ther; 2017 Feb 14; 35(1):3-9. PubMed ID: 27580017
    [Abstract] [Full Text] [Related]

  • 16. Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors.
    Nikolaou PE, Boengler K, Efentakis P, Vouvogiannopoulou K, Zoga A, Gaboriaud-Kolar N, Myrianthopoulos V, Alexakos P, Kostomitsopoulos N, Rerras I, Tsantili-Kakoulidou A, Skaltsounis AL, Papapetropoulos A, Iliodromitis EK, Schulz R, Andreadou I.
    Cardiovasc Res; 2019 Jun 01; 115(7):1228-1243. PubMed ID: 30843027
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardioprotective effect of anisodamine against ischemia/reperfusion injury through the mitochondrial ATP-sensitive potassium channel.
    Bai S, Wang X, Wu H, Chen T, Li X, Zhang L, Li X, Er L, Du R.
    Eur J Pharmacol; 2021 Jun 15; 901():174095. PubMed ID: 33862063
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.